| DVT | deep venous thrombosis |
|---|---|
| HATT | heparin-associated thrombocytopenia and thrombosis |
| HITT | heparin-induced thrombocytopenia and thrombosis |
| HITTS | heparin-induced thrombosis-thrombocytopenia syndrome |
| IVCT | inferior vena cava thrombosis; intravenously enhanced computed tomography |
| deep vein thrombosis | Blood clotting in the veins of the inner thigh or leg. In air travel, DVT is the economy-class syndrome. Even in young, health travelers the long stretches immobilised in cramped seats in cabins with very low humidity set the stage for the formation of a thrombus (blood clot) in the lower leg. Blood clots can break off (as an embolism) and makes its way to the luhg where it has the potential of causing respiratory distress and respiratory failure. (12 Dec 1998) |
|---|---|
| deep venous thrombosis | <cardiology> A blood clot that forms in a vein resulting in obstruction of venous flow. most common clinically in the lower extremities. (27 Sep 1997) |
| dilation thrombosis | Thrombosis due to slowed circulation consequent upon dilation of a vein. (05 Mar 2000) |
| thrombosis | <haematology> The formation, development or presence of a thrombus. (14 May 1997) |
| effort-induced thrombosis | <syndrome> Stress thrombosis or spontaneous thrombosis of the subclavian or axillary vein; a thoracic-outlet syndrome. Synonym: effort-induced thrombosis. (05 Mar 2000) |
| embolism and thrombosis | A collective term for diseases characterised by the formation, development, or presence of a thrombus (thrombosis) and the blocking of a vessel by the thrombus brought to its site by the blood current (embolism). (12 Dec 1998) |
| Venereal Disease Research Laboratory | <microbiology> A blood test used to diagnose syphilis. Read as nonreactive or negative if you do not have syphilis. The Venereal Disease Research Laboratory can also be positive is cases of leprosy, malaria, mononucleosis, lupus, hepatitis A and pregnancy. Positive Venereal Disease Research Laboratory tests are usually followed up by a more specific test (FTA antibodies). (12 Jan 1998) |
| Medical Research Council | <organisation> A UK Government funded body to promote the balanced development of medical and related biological research in the United Kingdom. It organises national clinical trials for the assessment of new treatment protocols for leukaemia and some of the related diseases. (05 Jan 1998) |
| research | Careful, a diligent search, a close searching, studious inquiry or examination. (18 Nov 1997) |
| research, controlled | The first controlled clinical research was probably done in 1875 by the british naval surgeon james lind who, on board the hms salisbury, gave sailors with scurvy either oranges or lemons or cider or vinegar or nutmeg (or another treatment) and after just six days discovered that the citrus-consuming sailors had recovered from scury, until then the scourge of extended sea voyages, while the sailors who had been given the other treatments remained uncured. (12 Dec 1998) |
| research design | A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. (12 Dec 1998) |
| research personnel | Those individuals engaged in research. (12 Dec 1998) |
| research support | Financial support of research activities. (12 Dec 1998) |
| peer review, research | The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions. (12 Dec 1998) |
| clinical nursing research | Research carried out by nurses in the clinical setting and designed to provide information that will help improve patient care. Other professional staff may also participate in the research. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|